The state of industry solutions to address challenges
Uncontrolled drug spend is substantially impacting profitability, while clinicians are lacking visibility to actionable formulary information at the point of decision.
Industry solutions are falling woefully short of delivering on these challenges beginning with insufficient Formulary & Benefit (F&B) information. This impacts offering the best drug recommendations while industry solutions lack therapeutic similar alternatives. In addition, Real-Time Prescription Benefit (RTPB) offerings today fall short without being guided by enriched F&B and smart alternatives.
$0M+
ANNUALIZED HEALTH PLAN SAVINGS
0M+
MEMBERS SERVED TO DATE
0%+
COVERAGE OF DRUG ALTERNATIVES
The power of intelligent ePrescribing
Announcing New Point-of-Care Partners Whitepaper